期刊
SEMINARS IN IMMUNOPATHOLOGY
卷 34, 期 1, 页码 151-165出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00281-011-0280-x
关键词
Anaphylatoxin; Coagulation; Complement; Fibrinolysis; Inflammation; Sepsis
资金
- U.S. National Institutes of Health [AI68730, AI30040, GM62134, GM29507, GM61656]
- Natural Sciences and Engineering Research Council of Canada
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730, N01AI030040] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029507, R37GM029507, R01GM061656, R01GM062134] Funding Source: NIH RePORTER
The parallel expression of activation products of the coagulation, fibrinolysis, and complement systems has long been observed in both clinical and experimental settings. Several interconnections between the individual components of these cascades have also been described, and the list of shared regulators is expanding. The co-existence and interplay of hemostatic and inflammatory mediators in the same microenvironment typically ensures a successful host immune defense in compromised barrier settings. However, dysregulation of the cascade activities or functions of inhibitors in one or both systems can result in clinical manifestations of disease, such as sepsis, systemic lupus erythematosus, or ischemia-reperfusion injury, with critical thrombotic and/or inflammatory complications. An appreciation of the precise relationship between complement activation and thrombosis may facilitate the development of novel therapeutics, as well as improve the clinical management of patients with thrombotic conditions that are characterized by complement-associated inflammatory responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据